Senior insider sale
Chief Operating Officer at KEROS THERAPEUTICS, INC. — senior position signals high conviction
$1.34M
85.31K shares
What this filing means
ROVALDI CHRISTOPHER plans to sell 85.31K shares of KEROS THERAPEUTICS, INC. valued at approximately $1.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2025ACC: 0001969223-25-000767
Officer· Chief Operating Officer
Since Feb 2022
85.31K
Shares to sell
$1.34M
Approx. market value
85.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/12/2025
85.31KTotal acquired85.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/12/2025 | Exercise of Stock Options Cash | 85.31K | — |
| Total | 85.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
85.31K
Market value
$1.34M
9/12/2025
Total
Units
85.31K
Value
$1.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/12/2025 | 85.31K | $1.34M | NASDAQ | Planned |
| Total | 85.31K | $1.34M | ||